Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
Rev1-CT/RIR PPI-IN-2
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Rev1-CT/RIR PPI-IN-2 (compound 10) is a translesion synthesis (TLS) inhibitor targeting the interaction of the Rev1 protein, with an IC50 of 13.7 μM and Kd of 40.8 μM, exhibiting anticancer properties. It enhances cisplatin-mediated cytotoxicity by disrupting the interaction between the C-terminal domain of TLS DNA polymerase Rev1 (Rev1-CT) and the Rev1 interaction region (RIR) of other TLS DNA polymerases. |
| Molecular Weight | 449.93 |
| Formula | C24H24ClN5O2 |
| Cas No. | 708283-84-5 |
| Smiles | ClC=1C=C(C=C(OC)C1OCC=2C=CC=CC2)CNC3=CC=C(C=C3)CNC4=NN=CN4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.